Skip to Content

Triacelluvax

Active Substance: diphtheria toxoid, haemagglutinin filamentous, adsorbed, pertactin, pertussis toxin, tetanus toxoid
Common Name: combined diphtheria, tetanus and acellular pertussis vaccine
ATC Code: J07AJ
Marketing Authorisation Holder: Chiron S.p.A.
Active Substance: diphtheria toxoid, haemagglutinin filamentous, adsorbed, pertactin, pertussis toxin, tetanus toxoid
Status: Withdrawn
Authorisation Date: 1999-01-11
Therapeutic Area: Diphtheria Whooping Cough Immunization Tetanus
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

TRIACELLUVAX is indicated for active immunisation of children from 6 weeks up to 7 years of age against diphtheria, tetanus and pertussis.

The marketing authorisation for Triacelluvax has been withdrawn at the request of the marketing authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide